Gastrointestinal Diagnostics Market Size, Growth, Trends | Report 2022-2030
The growth of the gastrointestinal diagnostics market is attributed to the increasing incidence of gastrointestinal disorders such as gastric infections, IBD, GERD, GI bleeding, and others. The market is further being driven by unhealthy eating habits coupled with a surge in obesity incidence and genetic factors that lead to GI diseases. Technological developments are creating an enhanced opportunity for automated gastrointestinal diagnostics and panels.
For instance, in May 2022, Qiagen announced the launch of CE approved automated syndromic testing QiaStat-Dx system, compatible with its gastrointestinal panel. The use of quick point-of-care diagnostic tests is rising owing to the convenience (ease of use) which is facilitating the launch of faster products to expedite the treatment. For instance, in April 2021, QuickNavi-H.pylori was launched by Otsuka Pharmaceutical Co., Ltd. which provides test results in 8 minutes.
The global market is segmented based on test type, technology, application, and test location. Among test types, the GI panel test segment held the largest share in 2021, owing to its rising adoption in the testing of gastric infections such as C. difficile infections. The enhanced focus of companies on tests for infectious diseases is attributable to the rising number of cases. For instance, in March 2022, Hardy Diagnostics became the exclusive U.S. distribution partner for BioCode MDx-3000 which offers Gastrointestinal Pathogen Panel (GPP).
North America held the largest segment share in 2021 and is projected to maintain its dominance over the forecast period. The market growth of North America is attributed to, increasing awareness of gastrointestinal diseases, the high prevalence of GI disorders, and the presence of advanced healthcare infrastructure. Moreover, high movement and strategic initiatives of leading players in the region contribute to the region’s expansion.
Asia Pacific is likely to be the fastest growing region during the projected period. The growth of the region is driven by, the presence of a large patient pool and the increasing geriatric population in the region. Further, the presence of untapped market potential and increasing demand for cost-efficient diagnostic solutions is anticipated to expedite the region’s growth.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Gastrointestinal Diagnostics Market
5.1. COVID-19 Landscape: Gastrointestinal Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Gastrointestinal Diagnostics Market, By Test Type
8.1. Gastrointestinal Diagnostics Market, by Test Type, 2022-2030
8.1.1. Endoscopy, Blood test
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. H. pylori test
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Calprotectin test
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Immunoglobulin A test
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Gastrointestinal Diagnostics Market, By Technology
9.1. Gastrointestinal Diagnostics Market, by Technology e, 2022-2030
9.1.1. PCR
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Microbiology
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. ELISA
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Gastrointestinal Diagnostics Market, By Application
10.1. Gastrointestinal Diagnostics Market, by Application, 2022-2030
10.1.1. Infection
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Inflammatory Bowel Disease
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Gastroesophageal Reflux Disease (GERD)
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Cancer
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Gastrointestinal Diagnostics Market, By Test Location
11.1. Gastrointestinal Diagnostics Market, by Test Location, 2022-2030
11.1.1. Central laboratories
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Point-of-Care
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Gastrointestinal Diagnostics Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.1.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.2.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.3.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.4.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Test Location (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Test Location (2017-2030)
Chapter 13. Company Profiles
13.1. BIOMERIEUX
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. F. Hoffmann-La Roche Ltd
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Abbott
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Beckman Coulter, Inc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Siemens Healthineers AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. DiaSorin S.p.A
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. QIAGEN, Hologic, Inc
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Meridian Bioscience
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers